Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze THC Tenet Healthcare Corporation. Please read: https://finlab.finance/en/setup?stock=THC

No install, open FinLab Studio

THC

Tenet Healthcare Corporation Healthcare As of 2026-07-31 Updated daily after market close

steady quality, fair valuation.

3 active signals
52-week adjusted-price high Top-quintile 6-month momentum EPS surprise beat
This page refreshes daily after the close. Add Tenet Healthcare Corporation to your watchlist to track signal changes on your next visit.
Valuation 50Quality 77Growth 66Momentum 87Risk / liquidity 68

Is Tenet Healthcare Corporation a buy? Fundamentals and valuation first

  • Quality is above average. Operating margin sits near the 69th percentile. TTM ROE is about 48.1%.

  • Valuation is middle-of-pack. TTM P/E is near the 57th percentile.

  • Recent volatility is moderate. 60-day annualized volatility is near the 59th percentile. Average 20-day dollar volume is about $315.3M.

  • Signals are active now. 52-week adjusted-price high, Top-quintile 6-month momentum, EPS surprise beat currently holds; the tables below show what followed in this stock’s own history.

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

27 historical occurrences (since 2018-03-02)
Average forward return after 52-week adjusted-price high。20-day: Win 57.7%, Sample 26, Median +2.83%, Excess +1.95%, Beat mkt rate 69.2%；60-day: Win 73.1%, Sample 26, Median +9.95%, Excess +4.43%, Beat mkt rate 65.4%；120-day: Win 52%, Sample 25, Median +6.18%, Excess +1.21%, Beat mkt rate 44%

120 days after: historical avg +5.78%

20-day +2.81%
60-day +8.54%
120-day +5.78%
20-day
60-day
120-day
Win
57.7%
73.1%
52%
Sample
26
26
25
Median
+2.83%
+9.95%
+6.18%
Excess
+1.95%
+4.43%
+1.21%
Beat mkt rate
69.2%
65.4%
44%

Over 25 occurrences, 120-day forward avg gained 5.78%, beat the market by 1.21 pts; win rate 52%.

Top-quintile 6-month momentum

Active · now 84%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

22 historical occurrences (since 2017-05-15)
Average forward return after Top-quintile 6-month momentum。20-day: Win 61.9%, Sample 21, Median +3.2%, Excess +3.3%, Beat mkt rate 71.4%；60-day: Win 66.7%, Sample 21, Median +9.01%, Excess +11.82%, Beat mkt rate 57.1%；120-day: Win 52.4%, Sample 21, Median +5.1%, Excess +16.08%, Beat mkt rate 57.1%

120 days after: historical avg +19.06%

20-day +3.79%
60-day +14.31%
120-day +19.06%
20-day
60-day
120-day
Win
61.9%
66.7%
52.4%
Sample
21
21
21
Median
+3.2%
+9.01%
+5.1%
Excess
+3.3%
+11.82%
+16.08%
Beat mkt rate
71.4%
57.1%
57.1%

Over 21 occurrences, 120-day forward avg gained 19.06%, beat the market by 16.08 pts; win rate 52.4%.

EPS surprise beat

Active · now 43.66197183098593%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

40 historical occurrences (since 2015-05-04)
Average forward return after EPS surprise beat。20-day: Win 62.2%, Sample 37, Median +7.05%, Excess +5.78%, Beat mkt rate 64.9%；60-day: Win 62.2%, Sample 37, Median +14.43%, Excess +10.52%, Beat mkt rate 56.8%；120-day: Win 60%, Sample 35, Median +11.49%, Excess +11.07%, Beat mkt rate 57.1%

120 days after: historical avg +17.39%

20-day +6.75%
60-day +14.1%
120-day +17.39%
20-day
60-day
120-day
Win
62.2%
62.2%
60%
Sample
37
37
35
Median
+7.05%
+14.43%
+11.49%
Excess
+5.78%
+10.52%
+11.07%
Beat mkt rate
64.9%
56.8%
57.1%

Over 35 occurrences, 120-day forward avg gained 17.39%, beat the market by 11.07 pts; win rate 60%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 233+32.9% +28% 97.9% +18.5%
20-40 You are here49+140% +169.5% 100% +109.2%
40-60 216+59.2% +51.6% 95.4% +36.8%
60-80 115+57.5% +60% 100% +36.1%
80-100 0Insufficient data

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 9.83, placing it in the 34.1 own-history percentile, inside the 20-40 bucket.

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
-1.7%
Win rate 32.7% Excess -8.1%
147d
Now
+25.4%
Win rate 80.8% Excess +15.9%
317d
+9.5%
Win rate 35.2% Excess +2.4%
88d
60-day momentum down
+30.9%
Win rate 97.7% Excess +23.6%
86d
+54.6%
Win rate 87.4% Excess +39.5%
95d
Insufficient data
(0d)

Currently in “Middle × 60-day momentum up”: across 317 historical days, 120-day forward avg gained 25.4%, win rate 80.8%, beat the market by 15.9%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 97,878 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.26%, a 58.3% positive-return rate, and +2.90 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.